ImmunityBio Inc
(NASDAQ: IBRX)

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

6.685 -

+0.145 (+2.22%)
价格区间 6.400 - 6.830   (6.72%)
开盘 6.530
昨收 6.540
6.680
买盘 701
6.690
卖盘 810
成交量 7,337,002
成交额 36,548,650
注释 -
数据延迟。最后一次更新13 Feb 2026 01:35.
数据提供商
查看所有活动


杰出贡献者

robinhan avatar
5702
追随者 2878
帖子 2898

Loading Chart...

Please login to view stock data and analysis